Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION

Last updated on 2024-03-12 History
Report ID 189237
Drug Identification Number 02423227
Brand name AMIODARONE HYDROCHLORIDE FOR INJECTION
Common or Proper name Amiodarone hydrochloride for injection
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) AMIODARONE HYDROCHLORIDE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 30
ATC code C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-04-11
Estimated end date 2025-01-31
Actual end date
Shortage status Actual shortage
Updated date 2024-03-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2024-03-12 French Compare
v17 2024-03-12 English Compare
v16 2023-12-30 French Compare
v15 2023-12-30 English Compare
v14 2023-05-11 French Compare
v13 2023-05-11 English Compare
v12 2023-05-11 French Compare
v11 2023-05-11 English Compare
v10 2023-05-11 French Compare
v9 2023-05-11 English Compare
v8 2023-05-10 French Compare
v7 2023-05-10 French Compare
v6 2023-05-10 English Compare
v5 2023-04-12 English Compare
v4 2023-04-11 French Compare
v3 2023-04-11 English Compare
v2 2023-04-11 French Compare
v1 2023-04-11 English Compare

Showing 1 to 18 of 18